Evidence map›Paper›PMID 36438478›Full record

ArticleTheranostics2022

Depletion of gut microbiota improves the therapeutic efficacy of cancer nanomedicine.

Ray Putra Prajnamitra, Yuan-Yuan Cheng, Chaw Yee Beh, Chien-Yi Lu, Jen-Hao Lin, Shu-Chian Ruan, Sheng-Lun Chen, Hung-Chih Chen, Ruey-Bing Yang, Patrick Ching-Ho Hsieh

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Microbiota matter.Nature materials · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Bacterial-Mediated Tumor Therapy: Old Treatment in a New Context.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ray Putra PrajnamitraInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Yuan-Yuan ChengInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Chaw Yee BehInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Chien-Yi LuInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Jen-Hao LinInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Shu-Chian RuanInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Sheng-Lun ChenInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Hung-Chih ChenInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Ruey-Bing YangInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Patrick Ching-Ho HsiehInstitute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Institute of Biomedical Sciences, Academia Sinica · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal MicrobiomeNanomedicineAnimalsDoxorubicinMiceNeoplasm Recurrence, LocalPolyethylene GlycolsDoxorubicinliposomal doxorubicinPolyethylene GlycolsGut microbiotaLipoDoxnanomedicinetriple-negative breast cancervascular permeability

Identifiers

PMID36438478
PMCPMC9691371
OpenAlexW4310463084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.